Allopurinol and Cardiovascular Outcomes in Patients with Ischaemic Heart Disease (Joint with Robertson Centre for Biostatistics, University of Nottingham and University College London)

Project Details

Effective start/end date1/09/131/04/21


  • National Institute for Health Research (11/36/41): £1,413,351.00

Research Output

Multicentre, prospective, randomised, open-label, blinded end point trial of the efficacy of allopurinol therapy in improving cardiovascular outcomes in patients with ischaemic heart disease: protocol of the ALL-HEART study

Mackenzie, I. S., Ford, I., Walker, A., Hawkey, C., Begg, A., Avery, A., Taggar, J., Wei, L., Struthers, A. D., MacDonald, T. M. & ALL-HEART study group, 8 Sep 2016, In : BMJ Open. 6, 9, p. 1-9 9 p., e013774.

Research output: Contribution to journalArticle

Open Access
  • 25 Citations (Scopus)
    203 Downloads (Pure)